Literature DB >> 1329759

Arylamine N-acetyltransferase in human red blood cells.

A Ward1, D Hickman, J W Gordon, E Sim.   

Abstract

N-Acetyltransferase activities associated with erythrocytes from 20 individuals have been determined with p-aminobenzoic acid as substrate. A three-fold variation in Vmax is found. The N-acetyltransferase genotype of the individuals has been determined and there is no correlation between the extent of acetylation measured in the individuals' erythrocytes and the inheritance of alleles at the polymorphic NAT locus. Folate is confirmed to be an inhibitor of arylamine N-acetyltransferase activity measured in erythrocytes. The content of folate in erythrocytes of individuals also varies. The individual with the maximum folate content has the minimum N-acetyltransferase activity. The monomorphic N-acetyltransferase gene from individuals spanning the range of N-acetyltransferase activity have been amplified, using the polymerase chain reaction. The pattern of restriction enzyme digestion of the monomorphic N-acetyltransferase gene with a series of eight restriction enzymes is the same for individuals spanning the activity range of arylamine N-acetyltransferase in their erythrocytes.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1329759     DOI: 10.1016/0006-2952(92)90373-q

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  13 in total

1.  Over-expression, purification, and characterization of recombinant human arylamine N-acetyltransferase 1.

Authors:  Haiqing Wang; Gregory M Vath; Akane Kawamura; Caleb A Bates; Edith Sim; Patrick E Hanna; Carston R Wagner
Journal:  Protein J       Date:  2005-02       Impact factor: 2.371

2.  Chromosomal localization of human genes for arylamine N-acetyltransferase.

Authors:  D Hickman; A Risch; V Buckle; N K Spurr; S J Jeremiah; A McCarthy; E Sim
Journal:  Biochem J       Date:  1994-02-01       Impact factor: 3.857

3.  Reduced 4-aminobiphenyl-induced liver tumorigenicity but not DNA damage in arylamine N-acetyltransferase null mice.

Authors:  Kim S Sugamori; Debbie Brenneman; Otto Sanchez; Mark A Doll; David W Hein; William M Pierce; Denis M Grant
Journal:  Cancer Lett       Date:  2011-12-19       Impact factor: 8.679

4.  Acetylation of arylamines by the placenta.

Authors:  V A Smelt; H J Mardon; C W Redman; E Sim
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1997 Oct-Dec       Impact factor: 2.441

5.  Arylamine N-acetyltransferase in Balb/c mice: identification of a novel mouse isoenzyme by cloning and expression in vitro.

Authors:  S L Kelly; E Sim
Journal:  Biochem J       Date:  1994-09-01       Impact factor: 3.857

6.  Acetylation of p-aminobenzoylglutamate, a folic acid catabolite, by recombinant human arylamine N-acetyltransferase and U937 cells.

Authors:  R F Minchin
Journal:  Biochem J       Date:  1995-04-01       Impact factor: 3.857

7.  Probing the catalytic potential of the hamster arylamine N-acetyltransferase 2 catalytic triad by site-directed mutagenesis of the proximal conserved residue, Tyr190.

Authors:  Xin Zhou; Naixia Zhang; Li Liu; Kylie J Walters; Patrick E Hanna; Carston R Wagner
Journal:  FEBS J       Date:  2009-10-23       Impact factor: 5.542

8.  Human acetylator genotype: relationship to colorectal cancer incidence and arylamine N-acetyltransferase expression in colon cytosol.

Authors:  J W Rodriguez; W G Kirlin; R J Ferguson; M A Doll; K Gray; T D Rustan; M E Lee; K Kemp; P Urso; D W Hein
Journal:  Arch Toxicol       Date:  1993       Impact factor: 5.153

9.  NAT gene polymorphisms and susceptibility to Alzheimer's disease: identification of a novel NAT1 allelic variant.

Authors:  Nichola Johnson; Peter Bell; Vesna Jonovska; Marc Budge; Edith Sim
Journal:  BMC Med Genet       Date:  2004-03-17       Impact factor: 2.103

10.  Cloning and characterization of arylamine N-acetyltransferase genes from Mycobacterium smegmatis and Mycobacterium tuberculosis: increased expression results in isoniazid resistance.

Authors:  M Payton; R Auty; R Delgoda; M Everett; E Sim
Journal:  J Bacteriol       Date:  1999-02       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.